Accuri Cytometers Names New CEO
Prior to HandyLab, Mr. Williams has been president and chief executive officer of Genomic Solutions, an Ann Arbor-based life science instrumentation company. He led Genomic Solutions through a
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.